emideltide
asset
Involved in
- David Pope said he was concerned about emideltide’s potentially dangerous downstream consequences.
- The FDA advisory panel recommended that compounding pharmacies be allowed to manufacture the peptides epitalon and semax, and recommended against manufacturing emideltide.
- Emideltide failed voting passage by a tally of 6-7.
Statements attributed to it
Nothing in the record is attributed to this entity as a speaker.
Origin: first recognised while reading FDA advisory panel narrowly rejects compounding of one peptide, backs two others · 2026-09-11 07:34